Drug: faslodex Quarter: 2016Q3
Total Records: 283 Number of Pages: 15
| DRUGNAME | PT | EventCount |
|---|---|---|
| FASLODEX | Second primary malignancy | 3 |
| FASLODEX | Abdominal pain | 2 |
| FASLODEX | Anal incontinence | 2 |
| FASLODEX | Ataxia | 2 |
| FASLODEX | Bone density decreased | 2 |
| FASLODEX | Bone lesion | 2 |
| FASLODEX | Chest discomfort | 2 |
| FASLODEX | Chest wall tumour | 2 |
| FASLODEX | Diabetes mellitus | 2 |
| FASLODEX | Drug intolerance | 2 |
| FASLODEX | Dysgeusia | 2 |
| FASLODEX | Epistaxis | 2 |
| FASLODEX | Fracture | 2 |
| FASLODEX | Gamma-glutamyltransferase increased | 2 |
| FASLODEX | Hepatic enzyme increased | 2 |
| FASLODEX | Hepatic neoplasm | 2 |
| FASLODEX | Hyperhidrosis | 2 |
| FASLODEX | Injection site necrosis | 2 |
| FASLODEX | Injection site reaction | 2 |
| FASLODEX | Injection site scab | 2 |
Total Records: 283 Number of Pages: 15